$1.84 Billion is the total value of CLOUGH CAPITAL PARTNERS L P's 132 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STARWOOD PPTY TR INCnote 4.375% 4/0 | $11,696,000 | +3.4% | 10,815,000 | 0.0% | 0.64% | +25.9% | ||
| TSM | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $9,348,000 | +1.6% | 77,800 | 0.0% | 0.51% | +23.6% | |
| ASHR | DBX ETF TRxtrack hrvst csi | $5,315,000 | +5.0% | 131,100 | 0.0% | 0.29% | +27.9% | |
| GOSSAMER BIO INCnote 5.000% 6/0 | $2,811,000 | -11.9% | 3,500,000 | 0.0% | 0.15% | +7.7% | ||
| REDWOOD TR INCnote 4.750% 8/1 | $2,008,000 | +1.7% | 1,978,000 | 0.0% | 0.11% | +23.9% | ||
| NTES | NETEASE INCsponsored ads | $983,000 | +11.7% | 8,525 | 0.0% | 0.05% | +35.9% | |
| JD | JD.COM INCspon adr cl a | $958,000 | -5.3% | 12,000 | 0.0% | 0.05% | +15.6% | |
| CENTER COAST BRKFLD MLP ENRG | $708,000 | +21.9% | 53,064 | 0.0% | 0.04% | +46.2% | ||
| KURA | KURA ONCOLOGY INC | $529,000 | -26.2% | 25,361 | 0.0% | 0.03% | -9.4% | |
| AFT | APOLLO SR FLOATING RATE FD I | $217,000 | +6.4% | 13,761 | 0.0% | 0.01% | +33.3% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Charles I. Clough, Jr. #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BK OF AMERICA CORP | 37 | Q3 2023 | 5.0% |
| MICROSOFT CORP | 35 | Q3 2023 | 5.5% |
| CITIGROUP INC | 33 | Q2 2021 | 5.8% |
| JPMORGAN CHASE & CO | 33 | Q3 2023 | 3.2% |
| D R HORTON INC | 32 | Q3 2023 | 3.2% |
| TRANSDIGM GROUP INC | 32 | Q3 2023 | 3.9% |
| VERTEX PHARMACEUTICALS INC | 32 | Q2 2023 | 1.6% |
| JAZZ PHARMACEUTICALS PLC | 32 | Q3 2023 | 1.6% |
| VERACYTE INC | 31 | Q2 2023 | 0.8% |
| LENNAR CORP | 30 | Q1 2022 | 2.7% |
View CLOUGH CAPITAL PARTNERS L P's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Checkmate Pharmaceuticals, Inc. | February 14, 2022 | 1,137,764 | 5.3% |
| Correvio Pharma Corp.Sold out | February 24, 2020 | 0 | 0.0% |
| Cardiome Pharma Corp | April 27, 2018 | 2,058,763 | 5.9% |
| CARVANA CO. | April 27, 2018 | 1,072,050 | 3.6% |
| HEALTHWAYS, INC | January 12, 2016 | 1,850,289 | 5.1% |
| Kura Oncology, Inc. | January 12, 2016 | 1,076,333 | 5.0% |
| VERACYTE, INC. | January 12, 2016 | 1,049,054 | 3.8% |
| Solar Senior Capital Ltd. | February 11, 2013 | 325,093 | 2.8% |
| MAGAL SECURITY SYSTEMS LTDSold out | March 23, 2011 | 0 | 0.0% |
| BIOSPHERE MEDICAL INCSold out | February 10, 2011 | 0 | 0.0% |
View CLOUGH CAPITAL PARTNERS L P's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
View CLOUGH CAPITAL PARTNERS L P's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.